Literature DB >> 23110006

Clinicopathological analysis of 21 thymic neuroendocrine tumors.

Soomin Ahn1, Jae Jun Lee, Sang Yun Ha, Chang Ohk Sung, Jhingook Kim, Joungho Han.   

Abstract

BACKGROUND: Thymic neuroendocrine carcinomas (NECs) are uncommon, for which there is no established information available because of a limited number of epidemiological study in Asia.
METHODS: We reviewed 21 cases of surgically resected thymic NECs, and evaluated their pathological and clinical features.
RESULTS: It showed male predominance (male/female ratio, 15/6) with wide age range from 20 to 72 years (mean age, 49 years). All 21 cases were divided into two types according to the World Health Organization criteria: atypical carcinoid (n=18) and large cell NEC (n=3). Three cases of atypical carcinoid (AC) were associated with ectopic Cushing's syndrome. All the patients (3/3) with large cell NEC (3/3) and 16.7% (3/18) of those with AC died of tumor progression. Common sites of metastasis included lung, lymph node, brain, lumbar spine, mediastinum, bone, and liver.
CONCLUSIONS: In conclusion, thymic neuroendocrine tumors carry a poor prognosis. Regarding the tumor classification, our results showed that a vast majority of carcinoids in the thymus correspond to ACs. In addition, our results also indicate that typical carcinoid is a very rare entity. Some cases of AC exhibited a large size, solid pattern and they showed aggressive clinical behavior, which highlights the spectrum of histologic appearances of thymic NECs.

Entities:  

Keywords:  Carcinoid tumor; Carcinoma, neuroendocrine; Thymus gland

Year:  2012        PMID: 23110006      PMCID: PMC3479770          DOI: 10.4132/KoreanJPathol.2012.46.3.221

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


  13 in total

1.  Neuroendocrine tumors (carcinoid) of the thymic gland.

Authors:  Ottavio Rena; Pier Luigi Filosso; Giuliano Maggi; Caterina Casadio
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

Review 2.  Carcinoid tumors and oat cell carcinomas of the thymus.

Authors:  J Rosai; G Levine; W R Weber; E Higa
Journal:  Pathol Annu       Date:  1976

3.  Atypical carcinoid tumor of the thymus with ectopic ACTH production developed during the course of etanercept treatment--case report.

Authors:  Ismail Simsek; Salih Pay; Ayhan Dinc; Hakan Erdem; Bulent Kurt
Journal:  Clin Rheumatol       Date:  2006-10-24       Impact factor: 2.980

Review 4.  Six cases of ectopic ACTH syndrome caused by thymic carcinoid.

Authors:  W Q Wang; L Ye; Y F Bi; H Y Zhao; S Y Sun; Z Y Tang; Y J Zhao; W Q Fang; Z Y Chen; K M Chen; X L Jin; G Ning
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

5.  Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases.

Authors:  C A Moran; S Suster
Journal:  Am J Clin Pathol       Date:  2000-07       Impact factor: 2.493

Review 6.  Primary neuroendocrine carcinomas of the mediastinum: review of current criteria for histopathologic diagnosis and classification.

Authors:  Cesar A Moran
Journal:  Semin Diagn Pathol       Date:  2005-08       Impact factor: 3.464

7.  Primary neuroendocrine tumours of the thymus: a clinicopathologic and prognostic study in 19 patients.

Authors:  Giuseppe Cardillo; Stefano Treggiari; Marinus A Paul; Francesco Carleo; Alessia Raffaella De Massimi; Daniele Remotti; Paolo Graziano; Massimo Martelli
Journal:  Eur J Cardiothorac Surg       Date:  2009-12-01       Impact factor: 4.191

8.  A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus.

Authors:  Olivier Tiffet; Andrew G Nicholson; Georges Ladas; Mary N Sheppard; Peter Goldstraw
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

9.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

10.  [Thymic carcinoid tumor with Cushing syndrome].

Authors:  Sanae Yamauchi; Y Yamada; T Tsushima; R Kitagawa; T Suto; D Kimura; I Fukuda
Journal:  Kyobu Geka       Date:  2008-02
View more
  14 in total

Review 1.  Neuroendocrine tumors of the thymus and mediastinum.

Authors:  Hanibal Bohnenberger; Helen Dinter; Alexander König; Philipp Ströbel
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 2.  Neuroendocrine tumors of the thymus: the oncologist point of view.

Authors:  Nicolas Girard
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Paolo Bidoli; Stefania Canova; Diego Cortinovis; Maria Ida Abbate; Fiorella Calabrese; Nazarena Nannini; Francesca Lunardi; Giulio Rossi; Stefano La Rosa; Carlo Capella; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Barbara Valeri; Ugo Pastorino; Adriana Albini; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-04-27       Impact factor: 4.064

Review 4.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 5.  [Neuroendocrine neoplasms of the mediastinum].

Authors:  L Brcic; M Heidinger; H Popper
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

6.  Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy.

Authors:  Go Eun Bae; Yeon-Lim Suh; Ki Woong Sung; Jung-Sun Kim
Journal:  Korean J Pathol       Date:  2013-10-25

7.  Thymic large cell neuroendocrine carcinoma - a rare and aggressive tumor: a case report.

Authors:  Efared Boubacar; Gabrielle Atsame-Ebang; Sani Rabiou; Ammor Fatimazahra; Asmae Mazti; Ibrahim S Sidibé; Layla Tahiri; Nawal Hammas; Ouadnouni Yassine; Smahi Mohamed; Chbani Laila; El Fatemi Hinde
Journal:  J Med Case Rep       Date:  2017-06-12

8.  Incidental metastatic mediastinal atypical carcinoid in a patient with parathyroid adenoma: a case report.

Authors:  Zareen Kiran; Asma Ahmed; Owais Rashid; Saira Fatima; Faizan Malik; Saulat Fatimi; Mubassher Ikram
Journal:  J Med Case Rep       Date:  2017-03-26

9.  Resected thymic large cell neuroendocrine carcinoma: report of a case.

Authors:  Hiromitsu Domen; Yasuhiro Hida; Masaaki Sato; Haruka Takahashi; Tatsuru Ishikawa; Yosuke Shionoya; Midori Hashimoto; Kaoru Nishiyama; Yuma Aoki; Kazuho Inoko; Syotaro Furukawa; Kazuomi Ichinokawa; Hidehisa Yamada
Journal:  Surg Case Rep       Date:  2018-11-16

10.  Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.

Authors:  Young Bae Choi; Go Eun Bae; Na Hee Lee; Jung-Sun Kim; Soo Hyun Lee; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo
Journal:  J Korean Med Sci       Date:  2015-07-15       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.